Melanocyte Survival and Transformation: Hypoxia & P13 Kinase/Akt/mTOR Signaling
Melanocyte Survival and Transformation: Hypoxia & P13 Kinase/Akt/mTOR Signaling
批准号:
7319960
负责人:
MARIANNE Broome POWELL
金额:
$27.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2011-05-31
关键词:
AddressApoptosisApoptoticAutomobile DrivingBiological ProcessBypassCardiovascular systemCell CycleCell Cycle ProgressionCell DeathCell ProliferationCell physiologyChemopreventive AgentComplexConditionCutaneous MelanomaDermisDevelopmentDiseaseDrug resistanceEnvironmentEpidermisEventExtracellular MatrixFactor AnalysisGene AmplificationGenesGeneticGenetic TranscriptionGlycogenHomeostasisHumanHypoxiaIn VitroIncidenceInvestigationKnockout MiceLesionLife ExpectancyMaintenanceMalignant - descriptorMalignant NeoplasmsMeasuresMediator of activation proteinMelanoma CellMetabolismModelingMolecularMusNormal tissue morphologyNumbersOncogenicOxygenOxygen measurement, partial pressure, arterialPTEN genePathway interactionsPhenotypePhosphotransferasesPhysiologicalProliferatingProtein BiosynthesisProteinsRangeReportingResearchResearch PersonnelResistanceRoleSignal PathwaySignal TransductionSkinSystemTherapeuticTransgenic MiceTranslationsXenograft procedureangiogenesiscell growthcell motilitygenetic elementglucose metabolismhuman FRAP1 proteinin vivomelanocytemelanomamouse modelpressureprogramspromoterras Oncogeneresponsesenescencesizetumortumor progressionupstream kinase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Malignant melanoma is a deadly malignancy due to its high propensity to metastatize and its resistance to existing therapies. There are currently no treatments that increase life expectancy once metastatic disease presents. Molecular analyses of familial and sporadic melanomas have identified a number of oncogenic alterations including Ras, B-Raf, PTEN, Akt, and Ink4a/Arf. Though Ras driven pathways have been studied for a number of years, we have observed significant differences in downstream effectors of Ras and in the complex biological functions that result under different physiologic contexts. Using a transgenic mouse with targeted expression of Ras in melanocytes we have experimentally validated the importance of expression of an activated Ras and downstream signaling pathways in melanoma development and tumor progression. The microenvironment of the tumor, in particular hypoxia, has been shown to act as a selective pressure effecting tumor progression and therapeutic resistance. We have found that the skin possess reduced oxygen tension that could both enhance the malignant potential of melanocytes with an activated Ras oncogene or Akt gene and may contribute to melanocyte survival, by passing senescence. Constitutive activation of Akt3, has been described in melanoma progression. Akt activation, both Ras-dependent and independent, leads to anti-apoptotic signaling as well as dysregulation of cap dependent translation. Using transgenic mice that we developed (Akt3 and Ras) and knock out mice (PTEN, VHL, HIF1a) and melanocytes cultured from these mice, we propose to identify the mechanism by which activation of the PI3kinse-Akt-mTOR pathway in the presence of a hypoxic microenvironment (or activated HIF1a) support melanocyte survival and promote melanocyte transformation. We will substantiate our observation in the mouse systems with studies of human melanocytic lesions and cultured human melanocytes and melanoma cells under similar conditions. Identification of the essential genetic elements in Akt pathway and the impact of the microenvironment of the skin on melanocyte survival and transformation provide crucial information for the development of effective therapeutic and chemopreventive agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Melanocyte Survival and Transformation: Hypoxia & P13 Kinase/Akt/mTOR Signaling
-
批准号:7626797
-
项目类别:
-
资助金额:$27.54万
-
财政年份:2007
-
负责人:MARIANNE Broome POWELL
-
依托单位:
Melanocyte Survival and Transformation: Hypoxia & P13 Kinase/Akt/mTOR Signaling
-
批准号:7455711
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2007
-
负责人:MARIANNE Broome POWELL
-
依托单位:
Melanocyte Survival and Transformation: Hypoxia & P13 Kinase/Akt/mTOR Signaling
-
批准号:7810593
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2007
-
负责人:MARIANNE Broome POWELL
-
依托单位:
Melanoma: Microenvironment and Oncogene Interactions
-
批准号:6477744
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2002
-
负责人:MARIANNE Broome POWELL
-
依托单位:
Melanoma: Microenvironment and Oncogene Interactions
-
批准号:6738954
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2002
-
负责人:MARIANNE Broome POWELL
-
依托单位:
Melanoma: Microenvironment and Oncogene Interactions
-
批准号:6890343
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2002
-
负责人:MARIANNE Broome POWELL
-
依托单位:
Melanoma: Microenvironment and Oncogene Interactions
-
批准号:6625621
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2002
-
负责人:MARIANNE Broome POWELL
-
依托单位:
CORE--GENETICALLY MODIFIED MICE
-
批准号:6323279
-
项目类别:
-
资助金额:$15.02万
-
财政年份:2000
-
负责人:MARIANNE Broome POWELL
-
依托单位:
EVALUATION OF CHEMOPREVENTIVE AGENTS USING A TRANSGENIC MOUSE MELANOMA MODEL
-
批准号:6352719
-
项目类别:
-
资助金额:$25.41万
-
财政年份:2000
-
负责人:MARIANNE Broome POWELL
-
依托单位:
EVALUATION OF CHEMOPREVENTIVE AGENTS USING A TRANSGENIC MOUSE MELANOMA MODEL
-
批准号:6218819
-
项目类别:
-
资助金额:$7.63万
-
财政年份:1999
-
负责人:MARIANNE Broome POWELL
-
依托单位:
CORE--GENETICALLY MODIFIED MICE
-
批准号:6295866
-
项目类别:
-
资助金额:$15.02万
-
财政年份:1999
-
负责人:MARIANNE Broome POWELL
-
依托单位:
CORE--GENETICALLY MODIFIED MICE
-
批准号:6101961
-
项目类别:
-
资助金额:$15.02万
-
财政年份:1999
-
负责人:MARIANNE Broome POWELL
-
依托单位:
CORE--GENETICALLY MODIFIED MICE
-
批准号:6217334
-
项目类别:
-
资助金额:$15.02万
-
财政年份:1999
-
负责人:MARIANNE Broome POWELL
-
依托单位:
CORE--GENETICALLY MODIFIED MICE
-
批准号:6269055
-
项目类别:
-
资助金额:$14.87万
-
财政年份:1998
-
负责人:MARIANNE Broome POWELL
-
依托单位:
EVALUATION OF CHEMOPREVENTIVE AGENTS USING A TRANSGENIC MOUSE MELANOMA MODEL
-
批准号:6269104
-
项目类别:
-
资助金额:$39.39万
-
财政年份:1998
-
负责人:MARIANNE Broome POWELL
-
依托单位:
EVALUATION OF CHEMOPREVENTIVE AGENTS USING A TRANSGENIC MOUSE MELANOMA MODEL
-
批准号:6102045
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:MARIANNE Broome POWELL
-
依托单位:
CORE--TRANSGENIC MOUSE RESOURCE
-
批准号:6236498
-
项目类别:
-
资助金额:$9.8万
-
财政年份:1997
-
负责人:MARIANNE Broome POWELL
-
依托单位:
EVALUATION OF CHEMOPREVENTIVE AGENTS USING A TRANSGENIC MOUSE MELANOMA MODEL
-
批准号:6236580
-
项目类别:
-
资助金额:$28.68万
-
财政年份:1996
-
负责人:MARIANNE Broome POWELL
-
依托单位:
IMMORTALIZATION AND TRANSFORMATION OF MELANOCYTES
-
批准号:2094492
-
项目类别:
-
资助金额:$10.64万
-
财政年份:1990
-
负责人:MARIANNE Broome POWELL
-
依托单位:
IMMORTALIZATION & TRANSFORMATION OF HUMAN MELANOCYTES
-
批准号:3459829
-
项目类别:
-
资助金额:$8.85万
-
财政年份:1990
-
负责人:MARIANNE Broome POWELL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: